Your browser doesn't support javascript.
loading
Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight loss.
Handelsman, Yehuda; Fain, Randi; Wang, Zhixiao; Li, Xuan; Fujioka, Ken; Shanahan, William.
Afiliação
  • Handelsman Y; a Metabolic Institute of America , Tarzana , CA , USA.
  • Fain R; b Department of Medical and Scientific Affairs , Formerly of Eisai Inc. , Woodcliff Lake , NJ , USA.
  • Wang Z; c Department of Health Economics & Outcomes Research, Eisai Inc. , Woodcliff Lake , NJ , USA.
  • Li X; c Department of Health Economics & Outcomes Research, Eisai Inc. , Woodcliff Lake , NJ , USA.
  • Fujioka K; d Department of Diabetes and Endocrinology , Scripps Clinic , La Jolla , CA , USA.
  • Shanahan W; e Department of Clinical Development , Formerly of Arena Pharmaceuticals, Inc. , San Diego , CA , USA.
Postgrad Med ; 128(8): 740-746, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27659698
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Benzazepinas / Diabetes Mellitus Tipo 2 / Agonistas do Receptor 5-HT2 de Serotonina / Obesidade Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Benzazepinas / Diabetes Mellitus Tipo 2 / Agonistas do Receptor 5-HT2 de Serotonina / Obesidade Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article